CLX vs GTBP · P/E 15, rev $7.10B vs $17.4M cap
The Clorox Company (CLX) versus GT Biopharma Inc (GTBP) — a side-by-side from cached financials, not a winner call.
The Clorox Company (CLX) is a household & personal products company listed on US.
GT Biopharma Inc (GTBP) is a biotechnology company listed on NASDAQ.
Latest reported CLX revenue for 2025-06-30 was $7.10B. Net income was $824.0M. CLX currently screens at market cap $10.89B and trailing P/E 14.6.
GTBP does not have a complete income-statement cache yet.
CLX currently screens at market cap $10.89B and trailing P/E 14.6. GTBP currently screens at market cap $17.4M.
Not investment advice. Open the CLX and GTBP stock pages for the full models.
Not investment advice.